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Abstract
Background: The HLA (human leukocyte antigen) class I is a kind of molecule encoded by a large family of genes
and is characteristic of high polymorphism. Now the number of the registered HLA-I molecules has exceeded 3000.
Slight differences in the amino acid sequences of HLAs would make them bind to different sets of peptides. In the
past decades, although many methods have been proposed to predict the binding between peptides and HLA-I
molecules and achieved good performance, most experimental data used by them is limited to the HLAs with a
small number of alleles. Thus they are inclined to obtain high prediction accuracy only for data with similar alleles.
Because the peptides and HLAs together determine the binding, it’s necessary to consider their contribution
meanwhile.
Results: By taking into account the features of the peptides sequence and the energy of contact residues, in this
paper a method based on the artificial neural network is proposed to predict the binding of peptides and HLA-I
even when the HLAs’ potential alleles are unknown. Two experiments in the allele-specific and super-type cases
are performed respectively to validate our method. In the first case, we collect 14 HLA-A and 14 HLA-B molecules
on Bjoern Peters dataset, and compare our method with the ARB, SMM, NetMHC and other 16 online methods.
Our method gets the best average AUC (Area under the ROC) value as 0.909. In the second one, we use leave one
out cross validation on MHC-peptide binding data that has different alleles but shares the common super-type.
Compared to gold standard methods like NetMHC and NetMHCpan, our method again achieves the best average
AUC value as 0.847.
Conclusions: Our method achieves satisfactory results. Whenever it’s tested on the HLA-I with single definite gene
or with super-type gene locus, it gets better classification accuracy. Especially, when the training set is small, our
method still works better than the other methods in the comparison. Therefore, we could make a conclusion that
by combining the peptides’ information, HLAs amino acid residues’ interaction information and contact energy, our
method really could improve prediction of the peptide HLA-I binding even when there aren’t the prior
experimental dataset for HLAs with various alleles.
Background
In the cellular immune system, peptide binding to MHC
(Major Histocompatibility Complex, in humans MHC is
also called Human Leukocyte Antigen HLA) is the most
selective step in recognition of pathogens. In humans,
there are three types of MHC molecules and their
recognizing, binding, transporting and functioning
mechanism are distinct. Taking the MHC-I for example.
Proteins in the cytosol are first degraded by the protea-
some, and then peptides are internalized by TAP (trans-
porter associating with antigen processing) channel in
the endoplasmic reticulum, where MHC-I molecules
freshly are synthesized. Complexes of MHC-I binding to
peptide enter Golgi apparatus and finally externalize on* Correspondence: liujuan@whu.edu.cn
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the cell membrane to interact with T lymphocytes.
Correctly and precisely predicting the T cell epitope has
realistic meaningfulness, especially important for the
vaccine design. Many experiments on analyzing the
binding complexes of peptide and MHC indicate that
the binding sites have the binding specificity. This speci-
ficity is usually determined by the molecular weight, the
electric charge, the pH value and other attributes. In the
past decades, many prediction methods have been pro-
posed to predict the epitope. They could be categorized
into the following types. The first one is the motif
matching based methods. From the binding complex
fragments of peptide and MHC, Rudensky [1] purified
and detected the amino acid sequences, from which
they proposed three binding motifs I-As, I-Ab, and I-Eb.
According to these three motifs, Cole [2] successfully
predicted MHC epitopes in the Sendai virus M protein.
Analogous methods by checking whether peptides have
the anchor sites matching with binding sites in the
MHC molecules include works [3-5]. This kind of meth-
ods is simple and easy to understand but the prediction
accuracy is not high. The second one is the scoring
matrix based method. It could be viewed as the generali-
sation of the motif matching based method. For each
type of MHC molecules, the existing peptide-MHC
binding data are statistically analysed to generate a coef-
ficient matrix, in which the element represents the
degree of amino acid contributing to the binding when
appearing in a certain position. Parker [6] used 154 syn-
thetic peptides to get the molecule HLA-A2 scoring
matrix; Kubo [7] got the HLA-A1, HLA-A3 and HLA-
A11 scoring matrix and Udaka [8] got H2-Kb, Db and
Lb scoring matrix respectively. Other similar methods to
build up MHC I class and class II molecules’ scoring
matrix include ProPred [9], ARB [10], SMM [11]. Given
the scoring matrix of one MHC molecule, the strength
of any peptide binding to it could be calculated in an
addition or a multiple way. In comparison with the first
type method, they usually have higher accuracy, but
there still exist some shortcomings like that they assume
each amino acid residue to independently affect the
binding and ignore the interactions among the amino
acid residues. In order to further improve the prediction
accuracy, some methods try to consider the whole pep-
tide sequence and establish more complex models to
reflect the real situation. This category of methods
includes the Bayesian method (Bayesian) [12], HMM
(Hidden Markov Model) [13], SVM (Support Vector
Machine) [14], ANN (Artificial Neural Network) [15]
and so on [16-21]. Before the prediction, the training
process is essential for the prediction model. According
to the different types of training data used, previous stated
methods also could be categorized into the sequence-
based methods and the structure-based methods. They
have their own advantages and limitations. On one side,
the sequence-based methods always adopt machine-learn-
ing approaches that need large amount of training data.
When the training data is sufficient, they could get good
prediction accuracy. In fact, HLA-I is extremely poly-
morphic. For example, in the database IMGT/HLA (inter-
national ImMunoGeneTics project) [22] the number of
registered HLA-I (HLA-I has three major gene locus
HLA-A, HLA-B and HLA-C.) molecules has exceeded
3000 and that for HLA-II is over 1100. Unfortunately, for
most of HLA molecules with different alleles, there are
few or even no experimentally obtained binding complex
data to facilitate analysing their binding characteristics.
Even for those HLAs that have experimental data, by
2010, IMGT/HLA has deposited 893 allele sequences of
the HLA-A loci and 1534 allele sequences of the HLA-B
loci, which implies the wide existence of polymorphism.
Based on one frequently used dataset composed of 35
HLA-I molecules, the binding prediction accuracy of the
HLA-I and peptide is reported to reach average 0.9 AUC
(Area Under roc Curve), but this dataset is too special and
only accounts for a small part of the known HLA-I mole-
cules. Those HLAs with slightly different amino acid
sequences may have their own binding specificity to differ-
ent sets of peptides. Thus, these sequence-based methods
are biased towards the known alleles if they use special
training data and may have the over-fitting prediction pro-
blem. On the other hand, structure-based methods could
jump over the obstacles of sequence polymorphism and
directly take advantage of the MHC molecule complex’s
3D structures and use their empirical force fields as the
binding specificity to estimate the binding affinity. How-
ever, the available 3D structure dataset is insufficient. Now
there are only tens of HLA-I molecules’ 3D structures
resolved, so the accuracy of structure-based methods is
restricted by the inadequate number of 3D structures and
is usually lower than sequence-based methods.
In order to overcome the existing problems and achieve
better prediction accuracy, we still take machine-learning
strategy based on the sequencing data. As mentioned
above, HLA-I has more polymorphism than HLA-II. So
here we focus on the HLA-I and a method based on the
artificial neural network is proposed to predict on HLA-I
with unknown alleles where there are limited or even no
prior experimentally obtained dataset. Different from
other sequence-based methods using ANN, our method
not only considers peptide sequence information but also
HLAs’ amino acid residues and the energy of contact resi-
dues. With information integration, our method is
expected to predict the binding of peptide and HLA-I with
high accuracy.
The rest sections of this paper will be organized as
followed. In the method part, a method based on artifi-
cial neural network will be introduced, in which the
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HLAs interaction residues extraction and contact energy
computation will be described. The experiments on two
datasets will be implemented in the results and discus-
sion part. On dataset is on the benchmark dataset and
the other one is on the super-type dataset. The perfor-
mance of our method will be evaluated under these two
conditions by comparing with other methods. The last
part is the conclusion.
Methods
There’re lots of classifiers could be used for prediction.
Choosing a proper classifier relies on the application
contexts. Here, we use ANN (Artificial Neural Network)
classifier to predict the peptide and HLA-I binding. The
reasons for utilizing the ANN model are their advan-
tages of self-learning, self-adaptive and modelling non-
linear relationship. Some works [23,24] have proved that
ANN is suitable for the epitope prediction. Besides the
classifier, how to select the classification features is
another important step. Not all of HLA’s amino acids
take action in the binding process. Therefore, we will
first find out which amino acid residues really function
and then compute their contact energy. These promi-
nent features will be properly encoded and finally used
to predict. The Figure 1 gives the framework of our
method.
Interacting residues of HLA and peptide
The crystal structures of peptide-HLA binding com-
plexes show that although HLA molecules from the
same gene locus have different alleles, the complexes
have similar spatial structure. Madden [25] have
resolved the 3D structures of five complexes where dif-
ferent peptides binding to the same HLA-A*0201 mole-
cule. The results show they have similar structure and












Figure 1 The framework of our method. The input data contains two parts, one is the peptide and the other is HLA molecule. HLA molecules
will be processed by the steps of extracting interacting amino acid residues and computing the contact energy. Then they will be encoded as
the classification features and input into the established classifier to do the training and predict.
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Madden’s work, one approach to overcome the influ-
ence of coding genes’ polymorphism is to find out the
major common interacting sites of HLAs from the same
gene locus. We collect, calculate and finally get the fre-
quent function residues of HLA from the existing struc-
ture data of peptide-HLA binding complexes. All raw
peptide and HLA structure data come from the database
PDB (protein Data Base). In total, there’re 111 peptide-
HLA-A binding complexes and 87 peptide-HLA-B bind-
ing complexes used. When the distance of residues of
the HLA and peptide is less than 4 A˙, we think that
they interact. The results show that for HLAs from the
same gene locus, their amino acid residue interacting
sites are similar, which is consistent with the result of
Madden. We discard those residues of HLAs that inter-
act with peptides less than 5 times. The putative sites
are shown in the Figure 2(a) and Figure 2(b) respectively
for HLA-A and HLA-B.
Contact energy of amino acid residues
In fact, as the participants of binding interaction, amino
acid residues of HLA and peptide don’t independently
contribute to the binding. Therefore, it’s necessary to
take into account the interaction among the amino acid
Figure 2 Interacting residues. (a) is the binding sites of HLA-A and (b) is the binding sites of HLA-B. The column number represents the HLA
molecular residue index given by the IMGT/HLA database and the row number indicates the amino acid residue index of peptide with the
length 9. The grey cells in the grid indicate residues that have interaction between HLA and peptide.
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residues. The structure of a peptide-HLA complex is
decided by several forces such as the interaction
between amino acids and water molecules, the interac-
tion between amino acids and so on. Although there are
several forces, the interaction between amino acids plays
a major role. Generally, the protein structure could be
estimated by the amino acid sequence and the interac-
tion strength could be calculated by the classical electro-
magnetic theory. If the attracting strength between two
amino acid residues is great, their position will have
more chance to be near. Therefore, if there are sufficient
protein structure data, the mutual attracting strength
could be computed. In the structure biology, Miyazawa
and Jernigan [26] matrix has been widely used for com-
puting the protein sequence energy in different structure
templates. But there’s a limitation that Miyazawa and
Jernigan matrix takes the solvent as the reference status
and is usually accurate for nonpolar molecules interac-
tion. But it couldn’t ignore the interaction between
amino acids and water molecules. Thus, we use the B
matrix [27], which is based on Miyazawa and Jernigan
matrix but refers to the threonine, to get the contact
energy of amino acid residues.
Encode the peptide and HLA
For the existing prediction methods based on the artifi-
cial neural network, there are three approaches to encode
the peptide. The first one is the parse matrix, in which
each amino acid is represented by 19 zeros and 1 one.
The second one is BLOSUM matrix and the third one is
to select some attributes from the physical and chemical
properties of amino acids. Among them, BLOSUM
matrix usually has the best prediction accuracy and good
ability of distinguishing the amino acids. In this paper,
the BLOSUM matrix will encode peptides and the B
matrix of the contact energy of amino acid residues will
encode HLA sequence. Therefore, the encoding length
for the HLA-A and peptide binding is 239 dimensions, in
which 180 dimensions are for the peptide encoded by
BLOSUM matrix and 59 dimensions are for HLA-A
amino acid residues interacting with the peptides
encoded by the B matrix. The encoding length for the
HLA-B and peptide is 255 dimensions, in which 180
dimensions are for peptide encoded by BLOSUM matrix
and 75 dimensions are for HLA-B amino acid residues
interacting with the peptides encoded by the B matrix. In
order to better measure the difference of affinity and
facilitate the artificial neural network training. The affi-
nity will be transformed to the logarithm format varying
from 0 to 1 like [15].
affinity = 1 − log (IC50)
log (50000)
(1)
Build and train ANNBM
There’re several subtypes in the ANN. In this paper we
use the error back propagation feed-forward neural net-
work. Because HLA features are encoded by B Matrix,
our ANN predictor is also specially named as ANNBM.
Theoretical analysis proves that ANN with one single
hidden layer can map almost continuous relationship
function. Therefore we establish the ANNBM consisting
of three layers including an input layer, a hidden layer
and an output layer. Neural network’s input layer has
239 nodes for predicting peptide-HLA-A binding, while
neural network’s input layer has 255 nodes for predict-
ing peptide-HLA-B binding. The output layer has only
one node. It is the logarithmic value of binding affinity
between HLA and peptide.
When constructing the ANNBM, there is no golden
criterion to determine the number of nodes in the hid-
den layer. With less hidden nodes, the ability of learn-
ing from samples is poor and unable to reflect the
relationship perfectly; with excessive hidden nodes, it
may remember the noise in the samples leading to the
over learning problem and reduce the generalization
ability. In principle, the number of hidden nodes
depends on the training sample scale, the sample noise
and the complexity of the relationship. A common way
to set the number is called trail-and-error, so we test
the hidden nodes varying from 2 to 12. The hidden
layer with 9 nodes has gotten the minimum mean
square error.
In ANNBM, the activation function still used the sig-
moid function. For Sigmoid function when the input of





Because of this characteristic, for some learning algo-
rithms like the steepest descent algorithm, as the weights
and thresholds are far from its best, the gradient is very
small and leads to weights and the thresholds correction
is very small, so we use the RPROP method to do net-
work weights adjustment. RPROP takes into account
only the sign of the partial derivative over all patterns but
not the magnitude, and acts independently on each
weight. For each weight, if there is a sign change of the
partial derivative of the total error function compared to
the last iteration, the update value for that weight is mul-
tiplied by a factor h−, where h− is less than 1. If the last
iteration produces the same sign, the update value is
multiplied by a factor of h+, where h+ is greater than 1.
The update values are calculated for each weight in the
manner described as above, and finally each weight is
changed by its own update value, in the opposite direc-
tion of that weight’s partial derivative, so as to minimise
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the total error function. The parameter h+ is empirically
set to 1.2 and h− to 0.5.
Results and discussion
Experiment on the benchmark dataset
Bjoern Peters [28] collect peptide-MHC-I binding datasets
and builds a benchmark dataset. This benchmark dataset
comes from two research groups’ works. They are Ales-
sandro Sette in the La Jolla Gene and Immunology Insti-
tutes and Søren Buus in the Copenhagen University.
Although their experiment systems have several differ-
ences in binding the judging index, detecting targets, the
preparation of MHC molecules and the purity of peptides,
the format of their experiment output is the same. For
each peptide, the IC50/EC50 value is assigned to measure
its binding affinity. In order to evaluate the consistency of
experiment results from these two groups, Bjoern Peters
makes the cross validation and results show good consis-
tency. The benchmark finally contains 48 828 binding data
on 35 HLA-I molecules. In this paper, we pick up HLA-I
with the length 9 to validate our method.
From the table 1, we could see our ANNBM get the best
performance. And the prediction is independent with the
scale of dataset, which could be observed in the Figure 3.
More interesting, the whole prediction accuracy of
ANNBM is nearly similar with the second perfect result
from the NetMHC and they both belong to the ANN
model. Apparently, here the neural networks appear its
non-linear mapping advantage that could learn the high
order relationship from the training process. Therefore
ANN based methods get higher accuracy than SMM and
ARB. Besides the model selection, the differences in select-
ing and encoding of the features also determinate the clas-
sification accuracy. SMM and ARB are based on the
scoring matrix. NetMHC combines the sparse, BLOSUM
matrix and hidden Markov to encode peptides.
Remarkable, for the small peptide dataset such as
B*4002, B*4402, B*4403 and B*5701 molecules, ANNBM
outperforms the NetMHC and other methods. The four
peptides’ numbers are respectively 118, 119, 119 and 59.
ANNBM method in the four molecules gets the AUC,
respectively, 0.858, 0.824, 0.791 and 0.96, and NetMHC
method in the four molecules gets the AUC, respec-
tively, 0.754, 0.778, 0.763 and 0.826. We believe that the
ANNBM benefits from taking in account the interaction
information of HLA and peptides, whereas NetMHC
just encodes the peptides information that is insufficient
for ANN to learn the high order relationship under the
small datasets situations. Figure 4 shows that when
there’re enough training dataset the prediction of these
methods have no obvious difference just like HLA-
A*0201, but under the small dataset situation showed in
the Figure 5 ANNBM proves integrating sequence infor-
mation and energy of contact residues really could
improve the prediction accuracy. It isn’t hard to under-
stand when training data is sufficient, ordinary classifiers
could learn the relationship by large amount of training.
The outperformance of ANNBM in the small dataset
proves ANNBM effectively catches the key factors for
the prediction.
Prediction on unknown alleles dataset
If there is no prior binding dataset for a HLA molecule,
we could make use of the Sette and Sidney work [29] to
indirectly solve this obstacle. Sette and Sidney discover
that HLA-I class molecules could be divided into several
super classes according to their binding specificity.
Table 1 Prediction Results on Benchmark Dataset
Allele ANNBM ARB SMM NetMHC Other methods Peptides
A*0101 0.977 0.964 0.98 0.982 0.955 1157
A*0201 0.951 0.934 0.952 0.957 0.922 3089
A*0202 0.891 0.875 0.899 0.9 0.793 1447
A*0203 0.911 0.884 0.916 0.921 0.788 1443
A*0206 0.906 0.872 0.914 0.927 0.735 1437
A*0301 0.932 0.908 0.94 0.937 0.851 2094
A*1101 0.945 0.918 0.948 0.951 0.869 1985
A*2402 0.826 0.718 0.78 0.825 0.77 197
A*2601 0.950 0.907 0.931 0.956 0.736 672
A*2902 0.907 0.755 0.911 0.935 0.597 160
A*3101 0.923 0.909 0.93 0.928 0.829 1869
A*3301 0.915 0.892 0.925 0.915 0.807 1140
A*6801 0.88 0.84 0.885 0.883 0.772 1141
A*6802 0.883 0.865 0.898 0.899 0.643 1434
B*0702 0.966 0.952 0.964 0.965 0.942 1262
B*0801 0.968 0.936 0.943 0.955 0.766 708
B*1501 0.939 0.9 0.952 0.941 0.816 978
B*1801 0.848 0.573 0.853 0.838 0.779 118
B*2705 0.957 0.915 0.94 0.938 0.926 969
B*3501 0.873 0.851 0.889 0.875 0.792 736
B*4002 0.858 0.541 0.842 0.754 0.775 118
B*4402 0.824 0.533 0.74 0.778 0.783 119
B*4403 0.791 0.461 0.77 0.763 0.698 119
B*5101 0.894 0.822 0.868 0.886 0.82 244
B*5301 0.886 0.871 0.882 0.899 0.861 254
B*5401 0.911 0.847 0.921 0.903 0.799 255
B*5701 0.96 0.428 0.871 0.826 0.767 59
B*5801 0.972 0.889 0.964 0.961 0.899 988
AVG 0.909 0.791 0.874 0.901 0.796
Table 1 summarizes the comparative results between our ANNBM and the
methods in the Bjoern Peters work on the benchmark. We use the AUC (Area
Under roc Curve) of 5-folds cross validation as the prediction evaluation criterion.
In the table, the first column is the allele name, including 14 HLA-A class
molecules and 14 HLA-B class molecules. The columns from 2 to 5 are the AUC
value of 5-folds cross validation from the ANNBM、 ARB、 SMM and NetMHC
respectively. In addition, ANNBM is also compared to other 16 online prediction
methods including various outstanding classifiers like SVM (arbmatrix, bimas,
hlaligand, hla_a2_smm, libscore, mappp, mhcpathway, mhcpred, multipred,
netmhc, pepdist, predbalbc, predep, rankpep, svmhc and syfpeithi ) and the best
prediction value among them is listed in the column 6. The last column is the
number of peptides binding to the corresponding the HLA molecule.
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HLA molecules belonging to the same super class have
similar binding site structure. Sette and Sidney divide
the HLA-A into 5 super classes: A1、A2、A3、A24
and A26, and divide the HLA-B into 7 super classes:
B7、 B8、 B27、 B39、 B44、 B58 and B62. In this
part, we will validate ANNBM prediction performance
when there is no exact binding data for the HLA mole-
cules. Besides the Bjoern Peters’ dataset, another 6 HLA
molecules are added in from the IEDB [30]. We use the
leave-one-out method to do validation. Because the
ANN methods have shown better prediction than the
other methods on the benchmark dataset, here we only
do comparison among three analogous ANN methods.
Methods NetMHC and NetMHCpan come from the
works [7,31]. NetMHC is the one that has the closest
prediction accuracy in the benchmark testing. Here we
check whether it could keep performing well. The
NetMHCpan is another method designed to predict
peptide-HLA binding with unknown alleles. The author
of NetMHCpan is an experienced researcher focusing
Figure 3 Methods comparison. According to the results in the table 1, we divide results into HLA-A class group (a) and HLA-B class group (b)
and order them in ascendance based on the peptide number to measure the correlation between scale of dataset and classification accuracy.
The panels from left to right and up to down are the linear fitting between the peptide number (x axis) and accuracy (y axis) on five methods:
ANNBM, ARB, SMM, NetMHC, and Other methods. The right down picture is the standard deviation of the classification accuracy. We could see
ANNBM gets the smallest slope rate and standard deviation, which proves that ANNBM is most independent with dataset scale and stable.
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Figure 4 ROC curve of ANNBM、 ARB、 SMM、 NetMHC on HLA-A*0201.
Figure 5 ROC curve of ANNBM、 ARB、 SMM、 NetMHC on HLA-B*4402.
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on the MHC epitope prediction. His methods are widely
used as the golden standard to evaluate other ones.
Finally we get the result shown in table 2, in which the
first column is the name of allele, the second column is
the super class that the HLA molecule belongs to, col-
umns from third to fifth columns are the AUC value of
ANNBM, NetMHC and NetMHCpan and the last col-
umn is the number of peptides binding to the corre-
sponding HLA molecule.
Conclusions
We have developed an ANNBM method that can well
predict peptides binding to HLAs for which have limited
or even no prior exact experimentally obtained data.
Our method takes both peptide sequence information
and contact energy of amino acid residues into account,
and could give the quantitative binding affinity. Allele-
specific benchmark and super-type experimental data-
sets successfully validate this method. ANNBM is stably
Table 2 Prediction Results on Unknown Alleles Dataset
Allele Supertype ANNBM NetMHC NetMHCpan Peptides
A*0101 A1 0.854 0.672 0.873 1157
A*0201 A2 0.905 0.886 0.912 3089
A*0202 A2 0.840 0.784 0.815 1447
A*0203 A2 0.836 0.818 0.832 1443
A*0206 A2 0.883 0.826 0.847 1436
A*0301 A3 0.867 0.820 0.849 2094
A*1101 A3 0.879 0.851 0.866 1985
A*2301 A24 0.917 0.877 0.863 104
A*2402 A24 0.864 0.848 0.821 197
A*2403 A24 0.923 0.894 0.912 254
A*2601 A1 0.771 0.631 0.733 672
A*2902 A3 0.832 0.603 0.749 160
A*3001 A3 0.863 0.846 0.838 669
A*3002 A1 0.671 0.711 0.721 92
A*3101 A3 0.853 0.822 0.878 1869
A*3301 A3 0.838 0.699 0.763 1140
A*6801 A3 0.768 0.744 0.760 1141
A*6802 A2 0.812 0.664 0.669 1434
A*6901 A2 0.902 0.811 0.823 833
B*0702 B7 0.919 0.864 0.902 1262
B*1501 B62 0.687 0.536 0.750 978
B*1801 B62 0.823 0.775 0.729 969
B*3501 B7 0.805 0.737 0.762 736
B*4001 B44 0.852 0.818 0.870 1078
B*4002 B44 0.883 0.802 0.807 118
B*4402 B44 0.824 0.771 0.839 119
B*4403 B44 0.836 0.800 0.842 119
B*4501 B44 0.822 0.804 0.809 114
B*5101 B7 0.887 0.879 0.905 244
B*5301 B7 0.828 0.819 0.838 254
B*5401 B7 0.880 0.847 0.845 255
B*5701 B58 0.945 0.652 0.919 59
B*5801 B58 0.869 0.625 0.841 988
AVG 0.847 0.774 0.824
From table.2, we can see that ANNBM method obtains the higher average AUC value than NetMHCpan and NetMHC methods by 0.023 and 0.073. NetMHC
encoding method doesn’t take into account the HLA molecules information. Although the training data comes from the same super-type and acquires perfect
results on the allele specific benchmark dataset, the HLA differences in the same super class are not reflected, so it is not difficult to understand the NetMHC
prediction accuracy decreases and lower than those of ANNBM and NetMHCpan that encode HLA molecules information. Comparing the encoding method of
the HLA molecules between ANNBM and NetMHCpan, ANNBM uses the B matrix and each amino acid that could interact with peptide is denoted by a numerical
value, while NetMHCpan uses the BLOSUM matrix and a 20 dimensions vector to denote each amino acid. Obviously, ANNBM has higher efficiency in the storage
and computation. The average AUC of ANNBM is greater than that of NetMHCpan, especially on the A*0202 and B*3501, whose ROC curves are showed in
figure 6 and 7.
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Figure 6 ROC curve of ANNBM, NetMHC and NetMHCpan on A*0202.
Figure 7 ROC curve of ANNBM, NetMHC and NetMHCpan on B*3501.
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better than other methods, especially for the HLA mole-
cules with the small (< 200) sets of peptides.
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